DNAGinkgo Bioworks Holdings, Inc.
NYSE · US · Healthcare · Biotechnology · ginkgo.bio
9.170USD-2.86%Mkt Cap: 595.76M USDP/E: Last update: 2026-06-01

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell en…

Indicators:|

Key Statistics

Company
Market Cap595.76M USD
Enterprise Value649.33M USD
Revenue (TTM)151.40M USD
Gross Profit123.18M USD
Net Income (TTM)-312.76M USD
Revenue/Share2.666 USD
Last Price9.170 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees485
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-2.92
PEG
EV/EBITDA-2.47
EV/Revenue4.29
P/S4.04
P/B1.30
EPS (TTM)-5.38
EPS (Forward)-3.21
52W Range
5.37031% of range17.58
52W High17.58 USD
52W Low5.370 USD
Profitability
Gross Margin72.39%
Oper. Margin-366.51%
EBITDA Margin-173.38%
Profit Margin-183.81%
ROE-61.50%
ROA-27.93%
Growth
Revenue Growth-49.10%
Earnings Growth
Cash Flow & Leverage
Operating CF-171.06M USD
CapEx (TTM)7.67M USD
FCF Margin-51.47%
FCF Yield-13.08%
Net Debt37.24M USD
Net Debt/EBITDA-0.14
Balance Sheet
Debt/Equity0.86
Current Ratio5.15
Quick Ratio4.95
Book Value/Sh7.187 USD
Cash/Share5.717 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:40
Split DateAug 20, 2024
Analyst Consensus
Rating
Target (Mean)8.500 USD
Target Range5.000 USD12.00 USD
# Analysts2
Ownership
Shares Out.53.36M
Float47.85M
Insiders4.60%
Institutions68.67%
Short Interest
Short Ratio3.4d
Short % Float8.77%
Short % Out.6.93%
Shares Short4.52M
Short (prev mo.)6.10M
Technical
SMA 507.824 (+17.2%)
SMA 2009.654 (-5.0%)
Beta1.78
S&P 52W Chg27.70%
Avg Vol (30d)1.13M
Avg Vol (10d)943.77K
Technical Indicators
RSI (14)61.8
MACD0.2331
MACD Signal0.1482
MACD Hist.+0.0849
BB Upper10.59 USD
BB Middle8.759 USD
BB Lower6.929 USD
BB Width41.80%
ATR (14)0.6840 USD
Vol Ratio (20d)0.51x